Sign inJoin waitlistJoin the waitlist

PM

Paul Kelly Marcom

Adjunct Professor in the Department of Medicine · Duke Department of Medicine

Credentials: ·

History

Duke Department of Medicine
Present
Duke Cancer Institute
Present

Baylor College of Medicine
1989

Research

Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer
Journal of Clinical Oncology · 2005 · 1,039 citations
Whole-genome analysis informs breast cancer response to aromatase inhibition
Nature · 2012 · 823 citations
Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2020 · 711 citations

Harold Burstein
25 papers · 1 as a fellow
Eric Winer
23 papers
AW
Antonio Wolff
18 papers
Lisa Carey
18 papers
CH
Clifford Hudis
17 papers
KB
Kimberly Blackwell
16 papers · 1 as a fellow
William Gradishar
16 papers
Gretchen Kimmick
15 papers
Ingrid Mayer
14 papers
Benjamin Anderson
13 papers
Hope Rugo
13 papers
LG
Lori Goldstein
13 papers

Clinical trials

Trial to Evaluate Genomic Expression Profiles to Direct Preoperative Chemotherapy in Early Stage Breast Cancer
Principal investigator · Terminated · Phase 2
Duke University
2008–2013
A Pharmacogenomics Study for Breast Cancer Patients Undergoing Adjuvant Chemotherapy With Doxorubicin (A)/Cyclophosphamide ©) and/or Weekly Paclitaxel
Principal investigator · Completed
Duke University
2003–2014
Letrozole, Herceptin in Her2neu +, Estrogen Receptor [ER] and/or Progesterone Receptor [PR] Positive, MBC
Principal investigator · Completed · Phase 2
Duke University
2000–2005